FAIAZ RASUL: Open Payments
NPI 1942313010 · COCOA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 74 payments from 24 companies in 2025. Trend: 2023 $2,189 · 2024 $1,655 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $228 |
| ABIOMED | 4 | $164 |
| Novo Nordisk Inc | 8 | $144 |
| Janssen Pharmaceuticals, Inc | 1 | $116 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $89 |
| Exact Sciences Corporation | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| PFIZER INC. | 4 | $60 |
Products named: SPRAVATO, VRAYLAR, JARDIANCE, UBRELVY, Cologuard Collection Kit, Kerendia, FARXIGA, LEQVIO.
Industry payments across FL — which companies pay providers there.
